Skip to main content
. 2022 Mar 6;13(5):1623–1629. doi: 10.7150/jca.69415

Table 1.

Clinical variables of subjects.

Characteristics LC (n=35) HD (n=35) P-value
Age, mean ± SD 57.69 ± 10.59 57.94 ± 6.29 0.9020
Gender, n (%)
male 21 (60.0%) 21 (60.0%)
female 14 (40.0%) 14 (40.0%)
Pathology, n (%)
adenocarcinoma 22 (62.9%)
squamous cell carcinoma 9 (25.7%)
small cell lung cancer 4 (11.4%)
Stage, n (%)
I 6 (17.2%)
II 0 (0.0%)
III 4 (11.4%)
IV 25 (71.4%)

Abbreviation: LC, lung cancer; HD, healthy donator.